Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective open-label study of atazanavir powder boosted with ritonavir liquid in pediatric HIV infection
2009-016361-28Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Primary endpoint: Safety of atazanavir powder + ritonavir liquid. Started Nov 2010; status: completed.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-016361-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016361-28.